Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging

International Journal of Pharmaceutics

Volumn 437, Issue 1-2, 2012, Pages 192-202

  Oh, Keun Sang ^a   Lee, Sangmin ^b   Na, Jin Hee ^b   Kim, Jeong Yeon ^c   Kim, Dong Eog ^c   Kim, Kwangmeyung ^a   Kwon, Ick Chan ^a   Yuk, Soon Hong ^d   Jeong, Seo Young ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

^d Korea University   (South Korea)

Author keywords

Cancer targeting therapy; Lipiodol ; Molecular imaging; Multifunctional nanoparticles; Pluronic F 68; Temperature induced phase transition

Indexed keywords

ACETONITRILE; CREMOPHOR; IODINATED POPPYSEED OIL; NANOPARTICLE; PACLITAXEL; POLOXAMER; POLYSORBATE 80;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG RELEASE; FLUORESCENCE; IN VITRO STUDY; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; ETHIODIZED OIL; HUMANS; MALE; MICE; MICE, INBRED C3H; MOLECULAR IMAGING; NANOPARTICLES; NEOPLASMS; PACLITAXEL; PHASE TRANSITION; POLOXAMER; POLYSORBATES; TEMPERATURE; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866740903     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.028     Document Type: Article

References (48)

1. B. Abu-Sharkh, and A. AlSunaidi Morphology and conformation analysis of self-assembled triblock copolymer melts Macromol. Theory Simul. 15 2006 507 515
2. K. Ahrar, and S. Gupta Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes Surg. Oncol. Clin. N. Am. 12 2003 105 126
3. S. Bloch, F. Lesage, L. McIntosh, A. Gandjbakhche, K. Liang, and S. Achilefu Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice J. Biomed. Opt. 10 2005 054003
4. S. Bose, and R.H. Bogner Solventless pharmaceutical coating processes: a review Pharm. Dev. Technol. 12 2007 115 131
5. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631-251
6. Y.W. Cho, S.A. Park, T.H. Han, D.H. Son, J.S. Park, S.J. Oh, D.H. Moon, K.J. Cho, C.H. Ahn, Y. Byun, I.S. Kim, I.C. Kwon, and S.Y. Kim In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications Biomaterials 28 2007 1236 1247
7. K.Y. Choi, H. Chung, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, I.C. Kwon, and S.Y. Jeong Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 31 2010 106 114
8. C. Christiansen X-ray contrast media - an overview Toxicology 209 2005 185 187
9. D. Dye, and J. Watkins Suspected anaphylactic reaction to Cremophor-EL Trends Biotechnol. 18 2000 412 420
10. U. Gaur, S.K. Sahoo, T.K. De, P.C. Ghosh, A. Maitra, and P.K. Ghosh Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system Int. J Pharm. 202 2002 1 10
11. B. Godin, W.H. Driessen, B. Proneth, S.Y. Lee, S. Srinivasan, R. Rumbaut, W. Arap, R. Pasqualini, M. Ferrari, and P. Decuzzi An integrated approach for the rational design of nanovectors for biomedical imaging and therapy Adv. Genet. 69 2010 31 64
12. K. Greish Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines J. Drug Target. 15 2007 457 464
13. J.M. Grindel, T. Jaworski, O. Piraner, R.M. Emanuele, and M. Balasubramanian Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans J. Pharm Sci. 91 2002 1936 1947
14. C. He, Y. Hu, L. Yin, C. Tang, and C. Yin Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31 2010 3657 3666
15. M.S. Hüttel, A. Schou Olesen, and E. Stoffersen Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR) Br. J Anaesth. 52 1980 77 79
16. K. Iwai, H. Maeda, and T. Konno Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image Cancer Res. 44 1984 2115 2121
17. D. Kim, Y.Y. Jeong, and S. Jon A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer ACS Nano 4 2010 3689 3696
18. R.M. Koffie, C.T. Farrar, L.J. Saidi, C.M. William, B.T. Hyman, and T.L. Spires-Jones Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging Proc. Natl. Acad. Sci. U.S.A. 108 2011 18837 18842
19. B.S. Lee, K. Park, S. Park, G.C. Kim, H.J. Kim, S. Lee, H. Kil, S.J. Oh, D. Chi, K. Kim, K. Choi, I.C. Kwon, and S.Y. Kim Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug J. Control. Release 147 2010 253 260
20. D.M. Lidgate, and N.E. Byars Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines Pharm. Biotechnol. 6 1995 313 324
21. Y. Ling, K. Wei, Y. Luo, X. Gao, and S. Zhong Dual docetaxel/ superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy Biomaterials 32 2011 7139 7150
22. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
23. S.M. Moghimi, and A.C. Hunter Poloxamers and poloxamines in nanoparticle engineering and experimental medicine Trends Biotechnol. 18 2000 412 420
24. C. Mugabe, Y. Matsui, A.I. So, M.E. Gleave, J.H. Baker, A.I. Minchinton, I. Manisali, R. Liggins, D.E. Brooks, and H.M. Burt In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer Clin Cancer Res. 17 2011 2788 2798
25. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm Res. 27 2010 2569 2589
26. K.S. Oh, J.Y. Song, S.H. Cho, B.S. Lee, S.Y. Kim, K. Kim, H. Jeon, I.C. Kwon, and S.H. Yuk Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy J. Control. Release 148 2010 344 350
27. K. Park, J.H. Kim, Y.S. Nam, S. Lee, H.Y. Nam, K. Kim, J.H. Park, I.S. Kim, K. Choi, S.Y. Kim, and I.C. Kwon Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles J. Control. Release 122 2007 305 314
28. 4 nanoparticles with robust incorporation of doxorubicin by thermo-responsiveness Int. J. Pharm. 424 2012 107 114
29. N. Passerini, B. Albertini, M.L. González-Rodríguez, C. Cavallari, and L. Rodriguez Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation Eur. J. Pharm Sci. 15 2002 71 78
30. N. Rapoport, A. Marin, Y. Luo, G.D. Prestwich, and M.D. Muniruzzaman Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization J Pharm Sci. 91 2002 157 170
31. N. Rapoport, Z. Gao, and A. Kennedy Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy J. Natl. Cancer Inst. 99 2007 1095 1106
32. K. Sakai-Kato, K. Ishikura, Y. Oshima, M. Tada, T. Suzuki, A. Ishii-Watabe, T. Yamaguchi, N. Nishiyama, K. Kataoka, T. Kawanishi, and H. Okuda Evaluation of intracellular trafficking and clearance from HeLa cells of doxorubicin-bound block copolymers Int. J. Pharm. 423 2012 401 409
33. E. Schick, L. Weber, and H. Gall Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid Contact Dermatitis 35 1996 312
34. L.K. Shah, and M.M. Amiji Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS Pharm Res. 23 2006 2638 2645
35. Y. Sheng, C. Liu, Y. Yuan, X. Tao, F. Yang, X. Shan, H. Zhou, and F. Xu Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan Biomaterials 30 2009 2340 2348
36. G. Storm, S.O. Belliot, T. Daemen, and D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
37. 2-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriers Int. J. Pharm. 423 2012 562 570
38. J. Szebeni, F.M. Muggia, and C.R. Alving Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study J. Natl Cancer Inst. 90 1998 300 306
39. J. Szebeni, C.R. Alving, S. Savay, Y. Barenholz, A. Priev, D. Danino, and Y. Talmon Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions Int. Immunopharmacol. 1 2001 721 735
40. P. Tang, F. Qiu, H. Zhang, and Y. Yang Morphology and phase diagram of complex block copolymers: ABC linear triblock copolymers Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 69 2004 031803-1-031803-8
41. A. Vaidya, Y. Sun, Y. Feng, L. Emerson, E.K. Jeong, and Z.R. Lu Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate Pharm Res. 25 2008 2002 2011
42. C. Wang, H. Tao, L. Cheng, and Z. Liu Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles Biomaterials 32 2011 6145 6154
43. M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharmacol. Res. 62 2010 90 99
44. H. Watanabe, H. Sueki, T. Nakada, M. Akiyama, and M. Iijima Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium Dermatology 198 1999 291 294
45. J.A. Webb, F. Stacul, H.S. Thomsen, and S.K. Morcos Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology. Late adverse reactions to intravascular iodinated contrast media Eur. Radiol. 13 2003 181 184
46. S.H. Yuk, K.S. Oh, S.H. Cho, S.Y. Kim, S. Oh, J.H. Lee, K. Kim, and I.C. Kwon Enhancement of the targeting capabilities of the paclitaxel-loaded Pluronic nanoparticles with a glycol chitosan/heparin composite Mol. Pharm. 9 2012 230 236
47. N. Zeng, Q. Hu, Z. Liu, X. Gao, R. Hu, Q. Song, G. Gu, H. Xia, L. Yao, Z. Pang, X. Jiang, J. Chen, and L. Fang Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability Int. J. Pharm. 424 2012 58 66
48. W. Zhang, Y. Shi, Y. Chen, J. Hao, X. Sha, and X. Fang The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models Biomaterials 32 2011 5934 5944